The life sciences ecosystem encompasses organisations from big pharma to biotech start-up, third sector to private equity / VC, all ultimately striving to positively impact people's lives and deliver tangible patient outcomes in an increasingly complex health environment. However, in this digital age, their noble work risks diminishing returns if technological progression is not embraced, and DX is not adopted - after all, no one wants to get left behind.